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Abstract: Heterogeneous copper on iron catalyst serves as an 
efficient alternative copper source for arylation reactions using 
hypervalent iodonium salts. The copper (0) catalyst affords 
meta-arylation of pivalanilides, while 2-ethynylanilides 
undergo oxidative carboarylation-ring closure with 
diaryliodonium salts. 
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The synthesis of biaryl systems and heterocyclic 
compounds via aromatic C-H bond functionalization 
and oxidative ring closure play important roles in 
organic chemistry. The biaryl motif and heterocyclic 
rings are often found in natural products and 
biologically active compounds.
1
 In traditional cross-
coupling reactions, prefunctionalization of the 
aromatic coupling partner and the utilization of 
metallo-organic reagents are required for efficient 
coupling. This chemical requirement for a coupling 
reaction leads to the formation of significant amount 
of byproducts originated from reagents, solvent or 
additives during the synthetic steps. To overcome 
these drawbacks, the use of C-H activation reactions 
serves as a useful alternative in which preactivation of 
the aromatic compounds is not necessary.
2
 A variety of 
substituted aryl groups can be regioselectively 
transferred through C-H functionalization in 
transition-metal catalyzed oxidative couplings with 
the aid of hypervalent iodonium salts.
3
 During the last 
decade several methods were developed, where 
diaryliodonium salts were applied for regioselective 
substitution of aromatic (ortho
4
- and meta-
5
 positions) 
and heteroaromatic compounds (C2 and C3 
substitution of indoles via palladium- and copper-
catalysis were reported).
6
 The choice of the catalyst 
often determines the site selectivity of the reactions.
7
 
In addition to the direct functionalization of C-H bond 
with iodonium salts, several methods were developed 
recently for the construction of heterocycles in 
copper-catalyzed oxidative ring closures using 
iodonium salts. Based on this strategy, 
pyrroloindolines were synthetized via an arylation-
cyclization cascade by MacMillan,
8
 the preparation of 
substituted oxazines was reported by Gaunt
9
 and an 
unusual 6-exo-dig cyclization of 2-ethynyl-anilides 
was developed in our laboratory yielding diversely 
substituted benzoxazines.
10 
The use of Cu(II)-species as precatalyst for C-H 
activation reactions performed under homogeneous 
catalytic conditions is prevalent.
6,7,11
 In these 
transformations, the most frequently used copper 
sources are Cu(OTf)2, CuCl2 and CuO. Although, the 
catalyst is added to the reactions as a Cu
2+
 salt, it is 
believed that Cu(I)-species are responsible for the 
catalytic activity.
7,12
 In general handling of copper(I) 
salts are difficult, while some of the copper(II) salts 
are toxic, air- and moisture sensitive, or expensive; 
therefore their use is not always practical. 
 
Scheme 1 Two possible approaches to the formation of Cu(I) 
species for C-H activation reactions. 
The catalytically active Cu(I) species can also be 
generated from Cu(0) (Scheme 1). Copper metal is 
cheap, easily accessible, and stable in air. Moreover, 
in some cases, its separation from the reaction mixture 
is quite simple. Interestingly, the use of elemental 
copper for the generation of Cu(I) species is rare in 
oxidative chemistry. As an example, application of Cu 
on AlO(OH) for meta-selective C-H bond arylation 
was reported by Park et al.
13
  
Previously our research group has developed a 
heterogeneous copper on iron catalyst, which is 
composed of copper nanoparticles on the surface of 
micron sized iron particles. The catalyst composition 
can be easily prepared from readily available reagents 
such as iron powder and CuSO4 under aqueous 
conditions. Our copper on iron catalyst system 
contains 5 w/w% Cu, where the copper is 
electrochemically deposited on the surface of the iron. 
The heterogeneous catalyst can stir the reaction and 
also can be easily separated from the reaction mixture 
using an external magnetic field. Additionally, the use 
of Cu/Fe catalyst significantly reduced the copper 
contamination of the organic products.
14 
The Cu/Fe 
catalyst has already been successfully applied in C-S 
and C-N bond forming reactions by our research 
group.
15 
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We aimed to study the applicability of the copper on 
iron heterogeneous catalyst in two different novel 
oxidative coupling reactions utilizing hypervalent 
iodonium salts: 1. meta-selective arylation of 
pivalanilides,
7
 and 2. Synthesis of benzoxazine 
derivatives via carboarylation-ring closure reaction of 
ortho ethynyl anilides (Scheme 2.).
10
 
 
Scheme 2 Meta-selective arylation of substituted pivalanilides and 
oxidative ring closure of 2-arylethynyl anilides 
The applicability of copper on iron catalyst for the 
meta-selective arylation the reaction between 2-
methyl-pivalanilide and phenyl(mesityl)iodonium 
triflates was evaluated using the reaction conditions of 
the homogeneous version.
7
 To our delight, addition of 
1.5 equiv. mesityl(phenyl)iodonium triflate to the 
pivalanilide in the presence of 5 mol% 5 w/w% Cu/Fe 
provides 94% conversion (79% isolated yield, Table 1, 
entry 1) in DCE in 20 hours at 50
o
C. These conditions 
proved to be the most ideal set of parameters for the 
efficient coupling. 
The substrate scope of the reaction was evaluated 
using substituted pivalanilides (1a-d) bearing different 
functional groups (Me, t-Bu, OMe, Ph) in ortho 
position, which were prepared from commercially 
available anilines and pivaloyl chloride.
16
 The 
syntheses of aryl(mesityl)iodonium salts bearing 
COOEt, F, Cl and Br groups on the aryl part (2b-e) 
were carried out according to the modified
10
 
procedure of Olofsson.
17
  
Arylations of the four pivalanilide substrates (1a-d) 
were performed with substituted aryl mesityl 
iodonium salts (2b-e) (Table 1, Entries 2-13). 
Aromatic groups bearing esters function were 
straightforwardly introduced into the meta position of 
the anilides with 2b and the biaryl products (3b-d) 
were isolated in 54-83%, depending on the substituent 
of the anilide. Comparing the results among the 
halogen-substituted aryl iodonium salts, the highest 
yield were obtained in case of the bromo substituted 
derivatives (3k-m) (70-79%) while aromatic groups 
containing chloro (3h-j) and fluoro (3e-g) function 
gave lower yield on the average (47-74% and 53-
72%). 
After demonstrating the applicability of Cu/Fe catalyst 
in meta- selective arylation, we aimed to study its 
catalytic activity in other oxidative coupling reaction. 
 
Table 1 Substrate scope using different functional groups
a
 
 
Entry R1 R2 Product Yield (%) 
1 Me H 3a 79 
2 Me COOEt 3b 83 
3 OMe COOEt 3c 61 
4 Ph COOEt 3d 54 
5 Me F 3e 57 
6 t-Bu F 3f 68 
7 Ph F 3g 53 
8 Me Cl 3h 65 
9 t-Bu Cl 3i 47 
10 Ph Cl 3j 74c 
11 Me Br 3k 75 
12 t-Bu Br 3l 79 
13 Ph Br 3m 70c 
a 
Reaction conditions: The reactions were performed with 0.5 
mmol pivalanilide, 0.75 mmol aryl(mesityl)iodonium triflate and 
32.2 mg Cu/Fe catalyst in 2.5 ml 1,2-DCE at 50/ 70°C for 20-48 
hours. 
b 
yield of isolated product 
c
arylation reaction was conducted at 70 °C. 
A novel procedure was developed in our laboratory 
for the synthesis of 4-diarylmethylene-benzoxazines 
through oxidative ring closure of ethynylanilides with 
diaryliodonium salt, where Cu(OTf)2 was used as 
catalyst (Scheme 3). In continuation of our work, we 
aimed to examine the applicability of Cu/Fe catalyst 
in the oxidative carboarylation and ring closure 
reaction for the synthesis of benzoxazine derivatives. 
 
Scheme 3. Oxidative ring closure of 2-arylethynyl anilides under 
homogeneous catalytic conditions 
The optimization reactions were carried out with N-
(2-(phenylethynyl)phenyl)pivalamide and 1.2 equiv. 
mesityl(phenyl)iodonium triflate varying the solvent 
(Table 2, entries 1-4), the catalyst loading (Table 2, 
entries 5-7) and the temperature (Table 2, entries 8-
10). The highest conversion was reached when the 
reaction was performed in 1,2-dichloroethane at 50°C 
in the presence of 5 mol% Cu/Fe catalyst. This finding 
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is identical with the best condition applied in the 
homogeneous version of this transformation.
10
 
Table 2 Optimization of reaction conditions 
a
 
 
Entry Solvent  Cu/Fe (mol%) T / °C Conversion (%) 
1 THF 5 50 6 
2 DMF 5 50 0 
3 toluene 5 50 45 
4 1,2-DCE 5 50 89 
5 1,2-DCE 2.5 50 81 
6 1,2-DCE 5 50 89 
7 1,2-DCE 10 50 87 
8 1,2-DCE 5 25 14 
9 1,2-DCE 5 50 89 
10 1,2-DCE 5 80 76 
a
 reactions were performed in 0.1 mmol scale and GC-MS 
conversions were measured after 12 hours stirring under inert 
atmosphere. 
After the optimization process, we studied the 
substrate scope of the procedure. Several substituted 
arylethynyl-anilides were treated with 
mesityl(phenyl)iodonium triflate in the presence of 
Cu/Fe catalyst under the optimized reaction 
conditions. The 4-diphenylmethylenebenzoxazine (5a) 
was isolated with 58% yield (Table 3, entry 1). The 
presence of electron donating methyl group in all 
positions on the phenyl ring in 2-arylethynyl 
pivalanilides resulted in increased yields compared to 
the unsubstituted derivative, affording the desired 
products 5b-d in 67%, 66% and 71% yield 
respectively (Table 3, entries 2-4). The strongly 
electron donating methoxy group decreased the 
efficiency of the reaction and compound 5e was 
isolated in 37% (Table 3, entry 5). Arylethynyl anilide 
containing the chlorophenyl group (Table 3, entry 6) 
gave product 5f (68%), while the reaction using the 
substrate containing the strongly electron withdrawing 
nitro group provided the desired product (5g) in 50% 
yield (Table 3, entry 7). In cases where 
nonsymmetrically substituted alkene derivatives are 
formed, the 
1
H NMR measurements showed the 
presence of mixture of geometric isomers (The 
isomeric ratios are indicated in Table 3). 
After functionalization of different arylethynyl 
anilides with phenylmesityliodonium triflate, the 
diversity of the product structure was expanded with 
the use of substituted aryl(mesityl)iodonium triflates. 
Using para- and meta methyl substituted iodonium 
salts, the appropriate products (5b and 5c) were 
obtained in 44% and 61% yields respectively (Table 3, 
entry 8,9). 
Table 3 Substrate scope using different functional groups.
a
  
 
Entry R1 R2 R3 Product 
E/Z 
ratio 
Yield 
(%) 
1 tBu H H 5a - 58 
2 tBu p-Me H 5b 2/3 67 
3 tBu m-Me H 5c 2/3 66 
4 tBu o-Me H 5d 1/1.2 71 
5 tBu p-OMe H 5e 1/2 37 
6 tBu p-Cl H 5f 1/2.3 68 
7 tBu p-NO2 H 5g 2/7 50 
8 tBu H p-Me 5b 3/2 44 
9 tBu H m-Me 5c 1.8/1 61 
10 tBu H p-Cl 5f 9/5 54 
11 tBu H p-NO2 5h - 0 
12 tBu p-Me p-Me 5i - 31 
13 tBu m-Me m-Me 5j - 61 
14 tBu p-Cl p-Cl 5k - 59 
15 Ph H H 5l - 70 
a
 Reaction conditions: The reactions were performed with 0.35 
mmol 2-arylethynyl-anilide, 0.42 mmol aryl(mesityl)iodonium 
triflate and 22.2 mg Cu/Fe catalyst in 3 ml 1,2-DCE at 50°C for 
12-24 hours. 
The para-chloro substituted derivative (5f) was also 
successfully prepared in 54% isolated yield (Table 3, 
entry 10). When the reaction was carried out with (4-
nitrophenyl)(mesityl)iodonium triflate, the reaction 
did not afford the desired product (5h) (Table 3, entry 
11). Compounds containing substituents on the phenyl 
ring of both the iodonium salt and the 
arylethynylanilide were also successfully reacted in 
the Cu/Fe catalyzed reaction, and the expected 
products (5i-k) were isolated in 31-61% yield (Table 
3, entries 12-14).  
When the tert-butyl group of the amide moiety was 
replaced with phenyl group the reaction provided the 
appropriate benzoxazine product (5l) in 70% yield 
(Table 3, entry 15). 
In conclusion, we successfully extended the 
application of copper on iron catalyst in the field of 
coupling chemistry. We have shown that Cu/Fe can be 
efficiently utilized in meta-selective arylation 
reactions of ortho-substituted pivalanilides with 
diaryliodonium triflates. We also demonstrated that 
our copper on iron catalyst also serves as an efficient 
catalyst in ring closing reaction of 2-arylethynyl 
anilides and hypervalent iodonium salts for the 
preparation of diaryl substituted methylene-
benzoxazines in good yields. Furthermore the catalyst 
can be easily prepared, is stable in air, and is not 
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sensitive to heat. Its separation from reaction mixture 
can be simply achieved using an external magnetic 
field. These properties of the catalyst would make its 
use advantageous in the oxidative transformations 
examined compared to the previously used 
homogenous copper sources. 
 
1
H-NMR and 
13
C-NMR spectra were recorded on a 
Bruker Avance-250 spectrometer operating at 250 
MHz and 62.5 MHz using DMSO-d6 or CDCl3 as 
solvent. Chemical shifts are given in ppm relative to 
TMS, or to the residual solvent peak of DMSO and 
CDCl3 as internal standards. Coupling constants (J) 
are reported in Hertz (Hz). Infrared spectra were 
recorded on Bruker Alpha single-reflection diamond 
ATR spectrometer as solids or thin films. In the IR 
spectra, only the strongest/structurally most important 
peaks (n, cm
-1
) are listed. HRMS were measured on 
an Agilent Technologies 6210 Time of Flight mass 
spectrometer. Melting points were recorded on Büchi 
501 apparatus and are reported uncorrected. All 
solvents used were distilled using standard methods. 
1,2-dichloroethane were distilled from calcium 
hydride. All mixed solvent systems are reported as v/v 
solutions. All reactions were monitored by TLC using 
Merck DC pre coated TLC plates with 0.25 mm 
Kieselgel 60 F254. Visualization was performed with a 
254 nm UV lamp. M-CPBA was dried under high 
vacuum at room temperature and was stored under 
argon. All other chemicals were used as received 
without further purification. 
 
Supporting Information for this article is available 
online at http://www.thieme-
connect.com/ejournals/toc/synthesis.  
General procedure for the preparation of copper 
on iron catalyst 
A round-bottom flask was charged with iron powder 
(5.00 g, 89.5 mmol) and H2O (deoxygenated with 
argon) (50 mL). The mixture was stirred vigorously 
with a mechanical stirrer and a solution of CuSO4 
(126 mg, 0.79 mmol) in H2O (50 mL) was added 
dropwise under argon atmosphere over 1 h, and the 
stirring was continued for 3 h. The catalyst was 
separated with a magnet and washed with 
deoxygenated H2O (5×20 mL) then acetone (3×20 
mL) and dried under reduced pressure. 
General procedure for the meta-selective arylation 
of pivalanilides: 
0.5 mmol pivalanilide, 0.75 mmol iodonium salt and 
32.2 mg Cu/Fe (5 mol%) was measured into a 4 ml 
vial. 2.5 ml abs. DCE was added and the reaction 
mixture was stirred at 50/70 °C for 20/48hours. 
Reaction mixture was separated from the catalyst with 
a magnetic bar, then evaporated. Purification of the 
crude product was achieved with column 
chromatography using gradient elution. If needed, 
further purification was done by preparative thin layer 
chromatography. The products were dried in vacuum 
oven (at 30 °C). 
N-(4-methylbiphenyl-3-yl)pivalamide (3a)
7 
Followed the general procedure the reaction was 
performed with 57.3 mg (0.3 mmol) N-o-tolyl 
pivalanilide, 212 mg (0.45 mmol) mesityl(phenyl) 
iodonium triflate  and 19.2 mg (5 mol%) Cu/Fe for 20 
h at 50°C. After evaporation of the solvent the crude 
product was purified with column chromatography on 
silica gel with gradient elution (Hexanes-Ethyl acetate 
eluent: 75:1 → 50:1 →25:1 →20:1 →10:1 →5:1) 
affording the product as white solid (63 mg, 0.24 
mmol, 79%).  
Mp 109-110 °C (lit. 110-112 °C). Rf = 0.31 (Hexane-
EtOAc, 8:1). ) 
IR (solid): 3311; 3031; 2963; 2923; 2868; 1649; 1507; 
1486; 1455; 1395; 1275; 1204; 1165; 882 cm
-1
. 
1
H NMR (250MHz, CDCl3): δ = 1.28 (s, 9 H), 2.21 (s, 
3 H), 7.52 (dt, 6 H, J = 9.4 Hz), 7.54 (d, 2H, J = 7.5 
Hz), 8.12 (s, 1H). 
13
C NMR (250 MHz, CDCl3): δ = 17.7; 28.1; 40.2; 
121.8; 123.8; 127.5; 127.6; 127.9; 129.0; 131.1; 
136.6; 140.4; 141.0. 177.0  
MS (EI, 70 eV): m/z (%): 267 (30%); 210 (7%); 183 
(32%); 165 (9%); 115 (5%); 85 (5%); 57 (100%).  
 
Ethyl 4'-methyl-3'-pivalamidobiphenyl-4-
carboxylate (3b)
7 
Followed the general procedure the reaction was 
performed with 95.6 mg (0.5 mmol) N-o-tolyl 
pivalanilide, 408 mg (0.75 mmol) mesityl(4-
ethoxycarbonylphenyl)iodonium triflate  and 32.2 mg 
(5 mol%) Cu/Fe for 20 h at 50°C. After evaporation of 
the solvent the remained residue was dissolved in 10 
ml ethyl-acetate and extracted by 3x10 ml 1 M NaOH. 
The aqueous phase was washed by 10 ml ethyl-acetate 
and the organic phase was extracted again with 3x10 
ml 1 M NaOH. The two organic phases were united 
and dried on MgSO4. After evaporation of the solvent 
the crude product was purified with column 
chromatography on silica gel with gradient elution 
(Hexanes-Ethyl acetate eluent: 50:1 → 25:1 → 20:1 
→ 15:1 → 10:1 → 5:1) affording the product as white 
solid (141 mg, 0.42 mmol, 83%).  
Mp 115 °C. Rf = 0.18 (Hexane-EtOAc, 8:1) 
IR (solid): 3306; 2956; 2922; 2867; 1738; 1650; 1480; 
1395; 1363; 1275; 1239; 1214; 1168; 1093; 1048; 
1011; 941; 907; 883; 841 cm
-1
. 
1
H NMR (250MHz, CDCl3): 1.36 (s, 9H), 1.41 (t, 3H, 
J
1
=J
2
 = 7.00 Hz), 2.30 (s, 3H), 4.39 (q, 2H, J
1
=J
4
 = 
10.50 Hz, J
2
=J
3
 = 3.50 Hz), 7.27 (m, 3H), 7.67 (d, 2H, 
J = 4.00 Hz),  8.07 (d, 2H, J = 4.25 Hz),  8.24 (s, 1H).  
13
C NMR (250 MHz, CDCl3): δ =14.8; 17.8; 28.1;  
40.6; 61.4; 121.8; 123.9; 127.2; 128.7; 129.4; 130.5; 
131.4; 136.8; 139.1; 145.5; 167.0; 177.1.  
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MS (EI, 70 eV): m/z (%): 339.2 (100%); 294.1 (20%); 
255.2 (51%); 226.1 (22%); 181.1 (22%); 152.1 (11%); 
85.1 (11%).  
 
Ethyl 4'-methoxy-3'-pivalamidobiphenyl-4-
carboxylate (3c) 
Followed the general procedure the reaction was 
performed with 104 mg (0.5 mmol) N-o-
methoxyphenyl pivalanilide, 408 mg (0.75 mmol) 
mesityl(4-ethoxycarbonylphenyl) iodonium triflate 
and 32 mg (5 mol%) Cu/Fe for 20 h at 50°C. After 
evaporation of the solvent the remained residue was 
dissolved in 10 ml ethyl-acetate and extracted with 
3x10 ml 1 M NaOH. The aqueous phase was washed 
with 10 ml ethyl-acetate and the organic phase was 
extracted again with 3x10 ml 1 M. The two organic 
phases were united and dried on MgSO4. After 
evaporation of the solvent the crude product was 
purified with column chromatography on silica gel 
with gradient elution (Hexanes-Ethyl acetate eluent: 
50:1 → 25:1 → 20:1 → 15:1 → 10:1 → 5:1) 
affording the product as white solid (109 mg, 0.31 
mmol, 61%).  
Mp 80 °C. Rf = 0.27 (Hexane-EtOAc, 8/1). 
IR (solid): 3440; 2975; 2911; 2871; 2839; 1713; 1670; 
1605; 1594; 1537; 1506; 1477; 1431; 1404; 1365; 
1326; 1286; 1256; 1175; 1158; 1127; 1104; 1051; 
1019; 922; 893; 859; 811 cm
-1
.  
1
H NMR (250 MHz, CDCl3) δ = 1.27 (s, 9H), 1.33 (t, 
3H, J
1
=J
2
 = 7.00 Hz), 3.87 (s, 3H), 4.31 (q, 2H, J
1
=J
4
 
= 10.75 Hz , J
2
=J
3
 = 3.5 Hz),  6.87 (d, 1H, J = 4.25 
Hz), 7.23 (m, 1H), 7.60 (d, 2H, 4.25 Hz), 7.97 (d, 2H, 
J = 4.25 Hz), 8.11 (s, 1H), 8.75 (d, 1H, J = 1.0 Hz).
  
13
C NMR (250 MHz, CDCl3): δ =14.8; 28.0; 40.5; 
56.4; 61.3; 110.4; 118.8; 122.5; 127.1; 128.7; 129.0; 
130.3; 133.3; 145.4; 148.5; 167.1; 177.2.  
MS (EI, 70 eV): m/z (%): 355 (73%); 310 (11%); 271 
(20%); 256 (27%); 228 (7%); 200 (11%); 183 (7%); 
167 (16%); 139 (21%); 85 (5%); 57 (100%).  
HRMS: m/z [M + H]
+
 calcd for C21H25NO4: 356.1856; 
found: 356.1852.
 
Ethyl 4'-phenyl-3'-pivalamidobiphenyl-4-
carboxylate (3d) 
Followed the general procedure the reaction was 
performed with 127 mg (0.5 mmol) biphenyl-2-
pivalanilide, 408 mg (0.75 mmol) mesityl(4-
ethoxycarbonylphenyl)iodonium triflate and 32 mg (5 
mol%) Cu/Fe for 20 h at 70°C. After evaporation of 
the solvent the remained residue was dissolved in 10 
ml ethyl-acetate and extracted with 3x10 ml 1 M 
NaOH. The aqueous phase was washed with 10 ml 
ethyl-acetate and the organic phase was extracted 
again with 3x10 ml 1 M. The two organic phases were 
united and dried on MgSO4. After evaporation of the 
solvent the crude product was purified with column 
chromatography on silica gel with gradient elution 
(Hexanes-Ethyl acetate eluent: 50:1 → 25:1 → 20:1 
→ 15:1 → 10:1 → 5:1) affording the product as white 
solid (108 mg, 0.27 mmol, 54%).  
Mp 109-112 °C. Rf = 0.15 (Hexane-EtOAc, 8:1). 
IR (solid): 3377; 3084; 3054; 3033; 2966; 2928; 2871; 
1717; 1666; 1608; 1581; 1553; 1527; 1497; 1462; 
1443; 1421; 1394; 1367; 1310; 1270; 1211; 1177; 
1158; 1124; 1100; 1018; 1008; 930; 885; 856; 825 cm
-
1
. 
1
H NMR (250 MHz, CDCl3) δ = 1.04 (s, 9H), 1.34 (t, 
3H, J
1
 = J
2
 = 5.0 Hz), 4.32 (q, 2H, J = 7.5 Hz), 7.24-
7.49 (m, 8H), 7.67 (d, 2H, J = 7.5 Hz), 8.02 (d, 2H, J 
= 7.5 Hz), 8.68 (s, 1H). 
13
C NMR (250 MHz, CDCl3) δ = 14.7; 27.7; 40.3; 
61.3; 120.1; 123.0; 127.5; 128.7; 129.6; 130.4; 130.8; 
132.2; 136.1; 138.0; 140.6; 145.3; 167.0; 177.0. 
MS (EI, 70 eV): m/z (%): 401 (50%); 344 (10%); 317 
(28%); 288 (13%); 241 (14%); 207 (4%); 167 (5%); 
85 (4%); 57 (100%).  
HRMS: m/z [M + H]
+
 calcd for C26H27NO3: 402.2064; 
found: 402.2060.
 
N-(4'-fluoro-4-methylbiphenyl-3-yl)pivalamide 
(3e)
19 
Followed the general procedure the reaction was 
performed with 95.6 mg (0.5 mmol) N-o-tolyl 
pivalanilide, 368 mg (0.75 mmol) mesityl(4-
fluorophenyl) iodonium triflate and 32.2 mg (5 mol%) 
at 50 ˚C for 20 h. After evaporation of the solvent the 
crude product was purified with column 
chromatography on silica gel with gradient elution 
(Toluene-Hexanes-Ethyl acetate eluent : 25:25:1 → 
12.5:12.5:1 → 5:5:1) affording the product as yellow 
oil (purity 78%). For further purification the oil was 
dissolved in ethyl acetate and it was purified by 
preparative thin layer chromatography using Toluene: 
MeOH = 10/1 as eluent. The product was obtained as 
white solid (81 mg, 0.28 mmol, 57%).  
Mp 107-109 °C. Rf = 0.61 (Toluene-MeOH, 10:1). 
IR (solid): 3299; 3034; 2962; 2928; 2870; 1649; 1598; 
1571; 1510; 1492; 1455; 1389; 1367; 1289; 1262; 
1222; 1202; 1158; 1096; 1014; 932; 876; 839 cm
-1
.
 
1
H NMR (250MHz, CDCl3): δ = 1.27 (s, 9H), 2.19 (s, 
3H), 6.99 (t, 2H, J
1
 = J
2
 = 8.5 Hz), 7.14 (s, 2H), 7.26 
(s, 1H), 7.47 (m, 2H), 8.07 (s, 1H). 
13
C NMR (250 MHz, CDCl3): δ = 17.7; 28.1; 40.2; 
121.8; 123.8; 127.5; 127.9; 129.0; 131.1; 136.6; 
140.4; 141.0; 177.1.  
MS (EI, 70 eV): m/z (%): 285.1 (54.2%); 228.1 
(4.2%); 201.1 (45.8%); 170.1 (7.5%); 133.1 (4.2%); 
85.1 (6.7%); 57.1 (100%).  
N-(4-tert-butyl-4'-fluorobiphenyl-3-yl)pivalamide 
(3f) 
Followed the general procedure the reaction was 
performed with 116.6 mg (0.5 mmol) N-o-t-
butylphenyl pivalanilide, 368 mg (0.75 mmol) 
mesityl(4-fluorophenyl) iodonium triflate and 32.2 mg 
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(5 mol%) Cu/Fe at 50˚C for 20 h. After evaporation of 
the solvent the crude product was purified with 
column chromatography on silica gel (Toluene: 
Hexanes-Ethyl-acetate eluent in 2.5:12.5:1 ratio) 
affording the product as yellow oil (purity: 82%). For 
further purification the oil was dissolved in ethyl 
acetate and it was purified by preparative thin layer 
chromatography using Toluene-MeOH, 10:1 as eluent. 
The product was obtained as white solid (111 mg, 0.34 
mmol, 68%).  
Mp 142°C. Rf = 0.65 (Toluene:MeOH, 10:1). 
IR (solid): 3265; 3004; 2960; 2932; 2870; 1645; 1507; 
1492; 1476; 1418; 1398; 1367; 1280; 1218; 1173; 
1158; 1095; 1046; 1027; 1014; 943; 909; 882; 842; 
820 cm
-1
;. 
1
H NMR (250MHz, CDCl3): δ = 1.29 (s, 9H), 1.37 (s, 
9H), 7.00 (t, 2H, J
1
 = J
2
 = 8.75 Hz), 7.20 (m, 1H), 
7.36 (d, 1H, J = 4.25 Hz), 7.47 (m, 3H), 7.88 (d, 1H, J 
= 2.0 Hz). 
13
C NMR (250 MHz, CDCl3): δ = 28.1; 31.0; 34.7; 
40.0; 115.7; 116.1; 124.2; 125.9; 127.4; 129.0; 129.1; 
136.4; 139.1; 140.8; 176.7.  
MS (EI, 70 eV): m/z (%):327 (21%); 270 (100%); 228 
(23%); 185 (9%); 57 (82%).  
HRMS: m/z [M + Na]
+
 calcd for C21H26NOF: 
350.1891; found: 350.1884.
 
N-(4'-fluoro-4-phenylbiphenyl-3-yl)pivalamide(3g) 
Followed the general procedure the reaction was 
performed with 127 mg (0.5 mmol) biphenyl-2-
pivalanilide, 368 mg (0.75 mmol) mesityl(4-
fluorophenyl) iodonium triflate and 32.2 mg (5 mol%) 
Cu/Fe at 50˚C for 20 h. After evaporation of the 
solvent the remaining residue was purified by flash 
chromatography on silica gel (Eluent: Hexanes-Ethyl 
acetate, 5:1) and the product was isolated with 71% 
purity as yellow oil. For further purification the oil 
was dissolved in ethyl acetate and it was purified by 
preparative thin layer chromatography using Toluene: 
Methanol = 10:1 as eluent. The pure product was 
obtained as white solid (92 mg, 0.26 mmol, 53%).  
Mp 115°C. Rf = 0.65 (Hexane-EtOAc, 5:1); Rf = 0.86 
(Toluene-MeOH, 10:1). 
IR (solid):  3428; 3064; 2970; 2955; 2928; 2864; 
1684; 1597; 1560; 1533; 1502; 1460; 1443; 1422; 
1394; 1361; 1306; 1211; 1155; 1122; 1096; 1076; 
1028; 1008; 919; 898; 846; 821 cm
-1
. 
1
H NMR (250MHz, CDCl3): δ = 1.13 (s, 9H), 7.12 (t, 
2H, J
1
 = J
2
 = 7.5 Hz), 7.50 (m, 8H), 7.66 (t, 2H, J = 
7.5 Hz), 8.70 (s, 1H). 
13
C NMR (250 MHz, CDCl3): δ = 28.0; 40.4; 115.8; 
116.2; 119.6; 119.7; 122.7; 128.6; 129.1; 129.3; 129.6; 
129.7; 131.4; 136.1; 138.2; 141.0; 177.0.  
MS (EI, 70 eV): m/z (%): 347 (92%); 290 (18%); 263 
(69%); 241 (8%); 167 (8%); 57 (100%).  
HRMS: m/z [M + Na]
+
 calcd for C23H22NOF: 
370.1578; found: 370.1583. 
 
N-(4'-chloro-4-methylbiphenyl-3-yl)pivalamide 
(3h) 
Followed the general procedure the reaction was 
performed with 95.6 mg (0.5 mmol) N-o-tolyl 
pivalanilide, 380 mg (0.75 mmol) mesityl(4-
chlorophenyl) iodonium triflate and 32.2 (5 mol%) mg 
Cu/Fe at 50˚C for 20 h. After evaporation of the 
solvent the crude product was purified with column 
chromatography on silica gel (Toluene: Hexanes: 
Ethyl acetate eluent in the ratio of 12.5:12.5:1) 
affording the product as yellow oil (purity:78%). For 
further purification the yellow oil was dissolved in 
ethyl acetate and it was purified by preparative thin 
layer chromatography using Toluene: Methanol = 10:1 
as eluent. The product was obtained as white solid (85 
mg, 0.28 mmol, 65%).  
Mp 148°C. Rf = 0.63 (Toluene-MeOH, 10:1). 
IR (solid):  3312; 3031; 2965; 2924; 2901; 2860; 
1649; 1612; 1517; 1499; 1479; 1455; 1397; 1382; 
1364; 1309; 1285; 1222; 1202; 1165; 1130; 1093; 
1083; 1038; 1011; 990; 957; 930; 906; 882; 834; 809; 
768 cm
-1
. 
1
H NMR (250MHz, CDCl3): δ = 1.27 (s, 9H), 2.19 (s, 
3H), 7.15 (brs, 2H), 7.27 (d, 3H, J = 4.25 Hz), 7.44 (d, 
2H, J = 4.25 Hz), 8.09 (s, 1H).  
13
C NMR (250 MHz, CDCl3): δ = 17.7; 28.1; 40.3; 
121.5; 123.5; 128.1; 128.7; 129.2; 131.3; 133.6; 
136.8; 139.0; 139.5; 177.1.  
MS (EI, 70 eV): m/z (%): 301 (27%); 244 (4%); 217 
(19%); 180 (7%); 152 (8%); 85 (7%); 57 (100%).  
HRMS: m/z [M + H]
+
 calcd for C18H20NOCl: 
302.1306; found: 302.1299.
 
N-(4-tert-butyl-4'-chlorobiphenyl-3-yl)pivalamide 
(3i) 
Followed the general procedure the reaction was 
performed with 116.6 mg (0.5 mmol) N-o-tolyl 
pivalanilide, 380 mg (0.75 mmol) mesityl(4-
chlorophenyl) iodonium triflate and 32.2 mg (5 mol%) 
Cu/Fe at 50˚C for 20 h. After evaporation of the 
solvent purification of the crude product with flash 
chromatography on silica gel (Hexanes-Ethyl acetate, 
5:1, as eluent) afforded the product as yellow oil 
(Purity: 79%). The yellow oil was dissolved in ethyl 
acetate and it was purified by preparative thin layer 
chromatography using Toluene-Methanol, 10:1 as 
eluent. The product is afforded as white solid (81 mg, 
0.24 mmol, 47%). 
Mp 122-144°C. Rf = 0.37 (Hexane-EtOAc, 5:1); Rf = 
0.74 (Toluene-MeOH, 10:1). 
IR (solid):  3306; 2956; 2922; 2867; 1738; 1650; 
1480; 1395; 1363; 1275; 1239; 1214; 1168; 1093; 
1048; 1011; 941; 907; 883; 841 cm
-1
. 
1
H NMR (250MHz, CDCl3): δ = 1.29 (s, 9H), 1.37 (s, 
9H), 7.25 (m, 3H), 7.37 (d, 1H, J = 4.13 Hz), 7.45 (d, 
3H, J = 4.25 Hz), 7.90 (d, 1H, J = 1.0 Hz). 
7 SYNTHESIS: PAPER  
Template for SYNLETT and SYNTHESIS © Thieme  Stuttgart · New York 2015-02-10 page 7 of 13 
13
C NMR (250 MHz, CDCl3): δ = 28.1; 31.0; 34.8; 
40.0; 124.2; 125.8; 127.5; 128.7; 129.2; 133.7; 136.5; 
138.8; 139.1; 141.2; 176.7.  
MS (EI, 70 eV): m/z (%): 343 (15%); 286 (100%); 
244 (18%); 193 (8%); 165 (11%); 57 (100%).  
HRMS: m/z [M + Na]
+
 calcd for C21H26NOCl: 
366.1595; found: 366.1593.
 
N-(4'-chloro-4-phenylbiphenyl-3-yl)pivalamide (3j) 
Followed the general procedure the reaction was 
performed with 127 mg (0.5 mmol) biphenyl-2-
pivalanilide, 380 mg (0.75 mmol) mesityl(4-
chlorophenyl) iodonium triflate and 32 mg (5 mol%) 
Cu/Fe at 70˚C for 20 h. After evaporation of the 
solvent purification of the crude product with flash 
chromatography on silica gel (Hexanes-Ethyl acetate, 
5:1 as eluent) the product as yellow oil (purity: 86%). 
For further purification the yellow oil was dissolved in 
ethyl acetate and it was purified by preparative thin 
layer chromatography using Toluene-Methanol, 10:1 
as eluent. The product was obtained as white solid 
(135 mg, 0.37 mmol, 74%).  
Mp 137°C. Rf = 0.48 (Hexane-EtOAc, 2:1). Rf = 0.75 
(Toluene-MeOH, 20:1). 
IR (solid):  3434; 3383; 3038; 2965; 2946; 2929; 
2867; 1677; 1581; 1551; 1523; 1486; 1470; 1460; 
1442; 1418; 1385; 1303; 1277; 1249; 1208; 1154; 
1127; 1087; 1025; 1007; 929; 882 cm
-1
. 
1
H NMR (250MHz, CDCl3): δ = 1.13 ppm (s, 9H), 
7.30 – 7.65 ppm (m, 12H), 8.71 ppm (d, J = 1.5 Hz, 
1H).
  
13
C NMR (250 MHz, CDCl3): δ = 27.5; 40.0; 119.4; 
122.3;  128.4; 128.6; 129.0; 129.3; 129.4; 130.3; 
131.4;  133.7; 135.8; 137.7; 139.1; 140.2; 176.5.  
MS (EI, 70 eV): m/z (%): 363 (28%); 306 (6%); 279 
(28%); 243 (13%); 85 (6%); 57 (100%).  
HRMS: m/z [M + Na]
+
 calcd for C23H22NOCl: 
386.1282; found: 386.1283.
 
N-(4'-bromo-4-methylbiphenyl-3-yl)pivalamide 
(3k)
13 
Followed the general procedure the reaction was 
performed with 95.5 mg (0.5 mmol) biphenyl-2-
pivalanilide, 413.4 mg (0.75 mmol) mesityl(4-
bromophenyl) iodonium triflate and 32.5 mg (5 
mol%) Cu/Fe at 50˚C for 20 h. After evaporation of 
the solvent purification of the crude product with flash 
chromatography on silica gel (Hexanes-Ethyl acetate, 
2:1 as eluent) afforded the product as yellow oil 
(purity: 89%). The yellow oil was solved in ethyl 
acetate and it was purified by preparative thin layer 
chromatography using Toluene-Methanol, 20:1 as 
eluent. Rf = 0.62. The product is afforded as white 
solid (129 mg, 0.37 mmol, 75%).  
Mp 141-142°C. Rf = 0.68 (Hexane-EtOAc, 2:1). 
(Toluene-MeOH, 20:1). 
IR (solid):  3312; 3030; 2965; 2924; 2861; 1738; 
1649; 1479; 1378; 1273; 1241; 1222; 1202; 1165; 
1070; 1044; 1007; 930; 905; 882; 884 cm
-1
.
 
1
H NMR (250MHz, CDCl3): δ = 1.36 (s, 9H), 2.28 (s, 
3H), 7.24 ppm (t, 2 H, J
1
 = J
2
 = 10.0 Hz), 7.50 (m, 
4H), 7.65 ppm (q, 2H, J = 7.5 Hz), 8.15 ppm (s, 1H).  
13
C NMR (250 MHz, CDCl3): δ = 17.7; 28.2; 40.4; 
121.5; 121.8; 123.6; 128.4; 129.0; 131.3; 132.1; 
136.7; 139.0; 140.0; 177.2.  
MS (EI, 70 eV): m/z (%): 345 (15%); 261 (14%); 180 
(9%); 153 (11%); 85 (6%); 57 (100%).  
N-(4'-bromo-4-tert-butylbiphenyl-3-yl)pivalamide 
(3l) 
Followed the general procedure the reaction was 
performed with 116.6 mg (0.5 mmol) N-o-t-butyl-
phenyl pivalanilide, 413.4 mg (0.75 mmol) mesityl(4-
bromophenyl) iodonium triflate and 32.5 mg (5 
mol%) Cu/Fe at 50˚C for 20 h. After evaporation of 
the solvent purification of the crude product with flash 
chromatography on silica gel (Hexanes-Ethyl acetate, 
5:1 as eluent) afforded the product as yellow oil 
(purity 78%). For further purification the yellow oil 
was dissolved in ethyl acetate and it was purified by 
preparative thin layer chromatography using Toluene-
Methanol, 10:1 as eluent. The product was obtained as 
white solid (153 mg, 0.39 mmol, 79%).  
Mp 126°C. Rf = 0.40 (Hexane-EtOAc, 5:1). Rf = 0.74 
(Toluene-MeOH, 20:1) 
IR (solid):  3305; 2956; 2921; 2902; 2867; 1737; 
1650; 1477; 1394; 1361; 1273; 1238; 1214; 1167; 
1095; 1070; 1048; 1007; 941; 906; 883 cm
-1
. 
1
H NMR (250 MHz, CDCl3) δ = 1.30 (s, 9H), 1.37 (s, 
9H), 7.21 – 7.32 (m, 1H), 7.46 – 7.54 (m, 6H), 7.91 
(d, J = 2.0 Hz, 1H).
  
13
C NMR (250 MHz, CDCl3) δ = 27.8; 30.7; 34.5; 
39.7; 121.6; 123.9; 125.5;  127.3; 128.8; 131.9; 136.2; 
138.5;  139.3; 141.0; 176.5.  
MS (EI, 70 eV): m/z (%): 387 (22%); 330 (100%); 
288 (24%); 251 (9%); 209 (7%); 193 (15%); 165 
(17%); 139 (7%); 57 (85%).  
HRMS: m/z [M + H]
+
 calcd for C21H26NOBr: 
388.1271; found: 388.1263.
 
N-(4'-bromo-4-phenylbiphenyl-3-yl)pivalamide 
(3m) 
Followed the general procedure the reaction was 
performed with 127 mg (0.5 mmol) biphenyl-2-
pivalanilide, 413.4 mg (0.75 mmol) mesityl(4-
bromophenyl) iodonium triflate and 32.5 mg (5 
mol%) Cu/Fe at 50˚C for 20 h. After evaporation of 
the solvent purification of the crude product with flash 
chromatography on silica gel (Hexanes-Ethyl acetate, 
5:1 as eluent) afforded the product as yellow oil 
(purity: 77%). For further purification the yellow oil 
was dissolved in ethyl acetate and it was purified by 
preparative thin layer chromatography using Toluene-
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Methanol, 10:1 as eluent. The product was obtained as 
white solid (143 mg, 0.35 mmol, 70%).  
Mp 119°C.
 
Rf = 0.60 (Hexane-EtOAc, 5:1). Rf = 0.86 
(Toluene-MeOH, 20:1).
 
IR (solid):  3430; 3081; 3062; 3023; 2970; 2953; 
2926; 2864; 1743; 1684; 1578; 1555; 1530; 1477; 
1460; 1445; 1421; 1384; 1304; 1279; 1245; 1209; 
1160; 1141; 1124; 1069; 1004; 919; 896 cm
-1
. 
1
H NMR (250 MHz, CDCl3) δ = 1.13 (s, 9H), 7.12 – 
7.74 (m, 12H), 8.71 (s, 1H). 
13
C NMR (250 MHz, CDCl3) δ = 27.5; 40.0; 119.3; 
121.9; 122.3; 128.4; 128.9; 129.3; 129.4; 130.4; 
131.5; 131.9; 135.8; 137.7; 139.6; 140.2; 176.7.  
MS (EI, 70 eV): m/z (%): 409 (25%); 407 (25%); 323 
(25%); 241 (19%); 57 (100%).  
HRMS: m/z [M + Na]
+
 calcd for C23H22NOBr: 
430.0777; found: 430.0780. 
General procedure for the synthesis of 2-tert-butyl-
4-(diarylmethylene)-4H-benzo[d][1,3]oxazines 
N-(2-(arylylethynyl)phenyl)pivalamide (0.35 mmol, 
1.0 equiv.), aryl(mesityl)iodonium 
trifluoromethanesulfonate (0.42 mmol, 1.2 equiv.) and 
Cu/Fe (22.2 mg, 0.0175 mmol, 5 mol%) were placed 
in a 4 ml vial, which was sealed with rubber septa, 
evacuated then charged with argon. 1,2-
dichloroethane (3 ml) was added, and the reaction 
mixture was stirred at 50°C for the indicated time. The 
catalyst was separated from the reaction mixture with 
a magnet. The reaction mixture was diluted with 
CH2Cl2 (15 ml), washed twice with saturated sodium 
bicarbonate solution (15 ml), the aqueous phase was 
extracted with CH2Cl2 (15 ml), and the combined 
organic phases were dried over magnesium sulphate 
and evaporated in vacuo. The crude product was 
purified by column chromatography. 
2-tert-butyl-4-(diphenylmethylene)-4H-
benzo[d][1,3]oxazine
10 
(5a) 
Prepared according to the general procedure from N-
(2-(phenylethynyl)phenyl)pivalamide (97.1 mg, 0.35 
mmol) with mesityl(phenyl)iodonium 
trifluoromethanesulfonate (198.4 mg, 0.42 mmol). 
Reaction time: 12 h. The crude product was purified 
by column chromatography on Brockmann II type 
neutral alumina with hexanes/ dichloromethane 100/ 1 
to give a yellow solid (72 mg, 0.203 mmol, 58%). 
Mp 167 – 169 °C. Rf: 0.72 (hexanes-ethyl acetate, 
7:1);  
IR (solid): 2975; 1640; 1615; 1597; 1456; 1219; 1136; 
1061 cm
-1
. 
1
H NMR (250 MHz, CDCl3): δ = 1.02 ppm (s, 9H, 
CH3); 6.54 ppm (d, J = 7.7 Hz, 1H, Ar-H); 6.68 ppm 
(ddd, J = 8.6 Hz and 5.9 Hz and 2.7 Hz, 1H, Ar-H); 
7.07 ppm (dd, J = 5.1 Hz and 2.0 Hz, 1H, Ar-H); 7.10 
– 7.16 ppm (m, 2H, Ar-H); 7.17 – 7.22 ppm (m, 8H, 
Ar-H). 
13
C NMR (62.5 Hz, CDCl3): δ = 27.5; 37.3; 120.7; 
121.6; 125.6; 126.0; 126.8; 127.0; 127.5; 127.8; 
129.1; 129.9; 130.0; 130.9; 140.1; 140.6; 141.3; 
141.6; 167.1. 
MS (EI, 70 eV): m/z (%): 353 (100%); 296 (45%); 
280 (10%); 268 (27%); 165 (36%); 57 (9%).  
 (E/Z)-4-((4-methylphenyl)(phenyl)methylene)-2-
tert-butyl-4H-benzo[d][1,3]oxazine
10
(5b) 
Prepared according to the general procedure from N-
(2-((4-methylphenyl)ethynyl)phenyl)pivalamide 
(102.0 mg, 0.35 mmol) with mesityl(phenyl)iodonium 
trifluoromethanesulfonate (198.4 mg 0.42 mmol). 
Reaction time: 12 h. The crude product was purified 
by column chromatography on Brockmann II type 
neutral alumina with hexanes-dichloromethane, 100:1 
to give a pale yellow solid (87 mg, 0.24 mmol, 67%). 
Isomer ratio E/ Z = 2/ 3 (from 
1
H NMR). 
Prepared according to the general procedure from N-
(2-(phenylethynyl)phenyl)pivalamide (97.1 mg, 0.35 
mmol) with 4-methylphenyl(mesityl)iodonium 
trifluoromethanesulfonate (204.2 mg 0.42 mmol), 
Reaction time: 18 h. The crude product was purified 
by column chromatography on Brockmann II type 
neutral alumina with hexanes/ dichloromethane 100/ 1 
to give a pale yellow solid (57 mg, 0.16 mmol, 44%). 
Isomer ratio E/ Z = 3/ 2 (from 
1
H NMR). 
Mp 108 – 110 °C; Rf: 0.73 (hexanes-ethyl acetate, 
7:1);  
IR (solid): 2959, 2925, 1636, 1594, 1455, 1275, 1219, 
1140, 1059, 828, 761, 695 cm
-1
. 
1
H NMR (250 MHz, CDCl3): δ = 1.02 ppm (s, 6H, 
CH3); 1.05 ppm (s, 9H, CH3); 2.26 ppm (s, 3H, CH3); 
2.27 (s, 2H, CH3); 6.51 ppm (d, J = 8.0 Hz, 1H, Ar-
H); 6.61 ppm (d, J = 8.0 Hz, 1H, Ar-H); 6.77 – 6.64 
ppm (m, 2H, Ar-H); 7.02 ppm (d, J = 8.7 Hz, 4H, Ar-
H); 7.12 – 7.05 ppm (m, 5H, Ar-H); 7.15 ppm (m, 3H, 
Ar-H); 7.21 ppm (m, 5H, Ar-H). 
13
C NMR (62.5 MHz, CDCl3): δ = 21.41; 27.5; 27.6; 
37.27; 37.30; 120.72; 120.75; 121.80; 121.84; 125.6; 
126.0; 126.7; 127.0; 127.4; 127.7; 128.4; 129.0; 
129.7; 129.8; 129.9; 130.0; 130.7; 130.9; 136.4; 
137.1; 137.2; 137.6; 140.3; 140.9; 141.4; 167.22; 
167.24. 
MS (EI, 70 eV): m/z (%): 367 (100%); 310 (63%); 
296 (28%); 282 (24%); 267 (25%); 178 (23%); 165 
(50%); 57 (30%).  
(E/Z)-4-((3-methylphenyl)(phenyl)methylene)-2-
tert-butyl-4H-benzo[d][1,3]oxazine
10 
(5c)  
Prepared according to the general procedure from N-
(2-((3-methylphenyl)ethynyl)phenyl)pivalamide 
(102.0 mg, 0.35 mmol) with mesityl(phenyl)iodonium 
trifluoromethanesulfonate (198.4 mg 0.42 mmol). 
Reaction time: 12 h. The crude product was purified 
by column chromatography on Brockmann II type 
neutral alumina with hexanes-dichloromethane 100:1 
to give a yellow solid (85 mg, 0.23 mmol, 66%). 
Isomer ratio E/ Z = 2/ 3 (from 1H NMR). 
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Prepared according to the general procedure from N-
(2-(phenylethynyl)phenyl)pivalamide (97.1 mg, 0.35 
mmol) with (3-methylphenyl)(mesityl)iodonium 
trifluoromethanesulfonate (204.2 mg 0.42 mmol) 
Reaction time: 12 h. The crude product was purified 
by column chromatography on Brockmann II type 
neutral alumina with hexanes-dichloromethane 100:1 
to give a yellow solid (79 mg, 0.21 mmol, 61%). 
Isomer ratio E/ Z = 1.8/ 1 (from 
1
H NMR). 
Mp 128 – 130 °C. Rf: 0.67 (hexanes-ethyl acetate, 
7:1);  
IR (solid): 3055; 3017; 2972; 2928; 2865; 1639; 1597; 
1455; 1219; 1139; 1062 cm
-1
. 
1
H NMR (250 MHz, CDCl3): δ = 1.02 ppm (s, 4.5H, 
CH3); 1.03 ppm (s, 9H, CH3); 2.18 ppm (s, 1.5H, 
CH3); 2.22 ppm (s, 3H, CH3); 6.53 ppm (t, J = 9.1 Hz, 
1.5H, Ar-H); 6.65 – 6.71 ppm (m, 1.5H, Ar-H); 6.92 – 
7.03 ppm (m, 4H, Ar-H), 7.06 – 7.09 ppm (m,5.5H, 
Ar-H); 7.13 – 7.24 ppm (m, 8H, Ar-H).
 
13
C NMR (62.5 Hz, CDCl3): δ = 21.5; 21.6; 27.5; 
37.3; 120.9; 121.7; 125.56; 125.59; 126.0; 126.7; 
127.0; 127.1; 127.5; 127.6; 127.7; 127.75; 127.82; 
128.3; 128.9; 129.1; 129.8; 130.0; 130.8; 130.9; 
131.4; 137.0; 138.7; 139.9; 140.7; 141.3; 141.5; 
167.2; 167.3. 
MS (EI, 70 eV): m/z (%): 367 (100%); 310 (60%); 
296 (30%); 282 (24%); 267 (28%); 178 (25%); 165 
(53%); 57 (31%).  
 (E,Z)-2-tert-butyl-4-((2-
methylphenyl)(phenyl)methylene)-4H-
benzo[d][1,3]oxazine
10 
(5d) 
Prepared according to the general procedure from N-
(2-((2-methylphenyl)ethynyl)phenyl)pivalamide 
(102.0 mg, 0.35 mmol) with mesityl(phenyl)iodonium 
trifluoromethanesulfonate (198.4 mg, 0.42 mmol) 
Reaction time: 12 h. The crude product was purified 
by column chromatography on silica gel hexanes-
ethyl acetate, 50:1 to give a yellow oil (91 mg, 0.25 
mmol, 71%). Isomer ratio E/ Z = 1/1.2 (from 
1
H 
NMR). 
Rf: 0.73 (hexanes-ethyl acetate, 7:1). 
IR (thin film): 3058; 3018; 2970; 2928; 2867; 1642; 
1598; 1456; 1273; 1218; 1139; 1061; 1029 cm
-1
. 
1
H NMR (250 MHz, CDCl3): δ = 0.89 ppm (s, 7.5H, 
CH3); 1.06 ppm (s, 9H, CH3); 2.01 ppm (s, 3H, CH3); 
2.23 ppm (s, 2.5H, CH3); 6.32 ppm (d, J = 7.7 Hz, 1H, 
Ar-H); 6.66 ppm (ddd, J = 8.6 Hz and 6.4 Hz and 2.3 
Hz, 1H, Ar-H); 6.75 ppm (m, 2H, Ar-H); 7.03 – 7.12 
ppm (m, 12H, Ar-H); 7.15 – 7.27  ppm (m, 9H, Ar-H).  
13
C NMR (62.5 Hz, CDCl3): δ = 19.9; 20.1; 27.2; 
27.5; 37.2; 37.4; 119.4; 119.9; 121.1; 122.0; 125.7; 
125.8; 126.0; 126.1; 126.4; 126.6; 126.8; 127.1; 
127.3; 127.7; 128.0; 128.9; 129.7; 129.8; 130.0; 
130.1; 131.0; 131.2; 136.6; 137.8; 139.0; 139.7; 
139.9; 141.0; 141.4; 141.48; 141.8; 167.1; 167.4. 
MS (EI, 70 eV): m/z (%): 367 (100%); 310 (55%); 
296 (23%); 282 (23%); 178 (47%); 165 (23%); 57 
(55%). 
 (E/Z)-2-tert-butyl-4-((4-
methoxyphenyl)(phenyl)methylene)-4H-
benzo[d][1,3]oxazine
10 
(5e)  
Prepared according to the general procedure from N-
(2-((4-methoxyphenyl)ethynyl)phenyl)pivalamide 
(107.6 mg, 0.35 mmol) with mesityl(phenyl)iodonium 
trifluoromethanesulfonate (198.4 mg 0.42 mmol) 
Reaction time: 24 h. The crude product was purified 
by column chromatography on silica gel with hexane-
ethyl acetate 50:1 to give a bright yellow oil (50 mg, 
0.13 mmol, 37%). Isomer ratio E/ Z = 1/ 2 (from 1H 
NMR) 
Rf: 0.61 (hexanes-ethyl acetate, 7:1). 
IR (thin film): 3058; 3031; 2958; 2925; 2853; 1639; 
1601; 1509; 1456; 1245; 1218; 1171; 1137; 1032; 834 
cm
-1
. 
1
H NMR (250 MHz, CDCl3): δ = 1.02 ppm (s, 4.5H, 
CH3); 1.07 ppm (s, 9H, CH3); 3.73 ppm (s, 3H, CH3); 
3.74 ppm (s, 1.5H, CH3); 6.50 ppm (d, J= 8.0 Hz, 1H, 
Ar-H); 6.72 – 6.59 (m, 1.5H, Ar-H); 6.77 ppm (d, J = 
8.8 Hz, 3H, Ar-H); 7.11 – 7.05 ppm (m,4H, Ar-H); 
7.19 – 7.12 ppm (m, 5H, Ar-H); 7.24 – 7.19 ppm (m, 
5H).  
13
C NMR (62.5 Hz, CDCl3): δ = 27.5; 27.6; 37.27; 
37.33; 55.4; 113.1; 114.5; 120.5; 121.9; 122.0; 125.55; 
125.61; 125.95; 126.03; 127.0; 127.5; 127.7; 129.0; 
129.7; 129.8; 130.0; 131.0; 131.3; 132.0; 132.6; 
140.9; 141.1; 141.3; 158.4; 167.3. 
(E,Z)-2-tert-butyl-4-((4-
chlorophenyl)(phenyl)methylene)-4H-
benzo[d][1,3]oxazine
10 
(5f)  
Prepared according to the general procedure from N-
(2-((4-chlorophenyl)ethynyl)phenyl)pivalamide 
(109.1 mg, 0.35 mmol) with mesityl(phenyl)iodonium 
trifluoromethanesulfonate (198.4 mg 0.42 mmol) 
Reaction time: 16 h. The crude product was purified 
by column chromatography on Brockmann II type 
neutral alumina with hexane-dichloromethane 100:1 
to give a pale yellow solid (92 mg, 0.24 mmol, 68%). 
Isomer ratio E/ Z = 1/ 2.3 (from 
1
H NMR).  
Prepared according to the general procedure from N-
(2-(phenylethynyl)phenyl)pivalamide (97.1 mg, 0.35 
mmol) with (4-chlorophenyl)(mesityl)iodonium 
trifluoromethanesulfonate (212.8 mg 0.42 mmol) 
Reaction time: 16 h. The crude product was purified 
by column chromatography on Brockmann II type 
neutral alumina with hexane/ dichloromethane 100/ 1 
to give a pale yellow solid (73 mg, 0.19 mmol, 54%). 
Isomer ratio E/ Z = 9/ 5 (from 1H NMR) 
Mp 121 – 123 °C. Rf: 0.70 (hexanes-ethyl acetate, 
7:1);  
IR (solid): 2695; 1638; 1594; 1487; 1455; 1219; 1140; 
1087; 1059; 1015; 832; 757 cm
-1
.  
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1
H NMR (250 MHz, CDCl3): δ = 1.01 ppm (s, 3.5H, 
CH3); 1.05 ppm (s, 9H, CH3); 6.51 ppm (d, J = 7.8 
Hz, 1H, Ar-H); 6.60 ppm (d, J = 7.9 Hz, 1H, Ar-H); 
6.69 ppm (m, 1H, Ar-H); 6.76 ppm (m, 0.4H, Ar-H); 
7.04 – 7.14 ppm (m, 6.5H, Ar-H); 7.16 – 7.24 ppm (m, 
10H, Ar-H). 
13
C NMR (62.5 Hz, CDCl3): δ = 27.5; 27.6; 37.3; 
119.3; 119.5; 121.2; 121.3; 125.76; 125.82; 126.1; 
126.2; 126.9; 127.0; 127.7; 127.9; 128.0; 129.2; 
129.3; 130.0; 130.1; 130.2; 130.9; 131.4; 132.3; 
133.4; 138.6; 139.2; 139.7; 140.3; 141.3; 141.4; 
142.1; 142.2; 166.8; 167.1. 
MS (EI, 70 eV): m/z (%): 387 (100%); 330 (50%); 
295 (20%); 267 (34%); 239 (20%); 165 (65%); 57 
(35%). 
2-tert-butyl-4-((4-nitrophenyl)(phenyl)methylene)-
4H-benzo[d][1,3]oxazine
10 
(5g)  
Prepared according to the general procedure from N-
(2-((4-nitrophenyl)ethynyl)phenyl)pivalamide (112.8 
mg, 0.35 mmol) with mesityl(phenyl)iodonium 
trifluoromethanesulfonate (198.4 mg 0.42 mmol) 
Reaction time: 17 h. The crude product was purified 
by column chromatography on Brockmann II type 
neutral alumina with hexanes-dichloromethane 100:1 
to give a bright yellow solid (70 mg, 0.18 mmol, 
50%). Isomer ratio E/ Z = 2/ 7 (from 1H NMR). 
Mp 130-132 °C. Rf: 0.53 (hexanes-ethyl acetate 7:1);  
IR (solid): 3061; 2958; 2922; 2851; 1639; 1578; 1511; 
1455; 1337; 1272; 1218; 1139; 1061 cm
-1
. 
1
H NMR (250 MHz, CDCl3): δ = 1.05 ppm (s, 2H, 
CH3); 1.09 ppm (s, 7H, CH3); 6.57 (d, J = 8.0 Hz, 1H, 
Ar-H); 6.77 ppm (t, J = 6.2 Hz, 1H, Ar-H); 7.23 – 7.11 
ppm (m, 4H, Ar-H); 7.34 – 7.26 ppm (m, 3H, Ar-H); 
7.42 ppm (d, J = 8.6 Hz, 2H Ar-H); 8.11 ppm (d, J = 
8.4 Hz, 2H, Ar-H). 
13
C NMR (62.5 Hz, CDCl3): δ = 27.5; 27.6; 37.4; 
118.2; 120.6; 123.2; 124.2; 126.1; 126.2; 126.4; 
126.9; 127.3; 127.5; 128.20; 128.22; 129.0; 129.6; 
130.2; 130.8; 130.9; 131.1; 131.9; 139.7; 141.4; 
144.1; 146.2; 147.2; 166.2. 
MS (EI, 70 eV): m/z (%): 398 (100%); 341 (38%); 
295 (70%); 267 (50%); 239 (33%); 165 (40%); 57 
(65%). 
4-(bis(4-methylphenyl)methylene)-2-tert-butyl-4H-
benzo[d][1,3]oxazine
10 
(5i)  
Prepared according to the general procedure from N-
(2-((4-methylphenyl)ethynyl)phenyl)pivalamide 
(102.0 mg, 0.35 mmol) with 4-
methylphenyl(mesityl)iodonium trifluoromethane-
sulfonate (204.2 mg 0.42 mmol) Reaction time: 12 h. 
The crude product was purified by column 
chromatography on Brockmann II type neutral 
alumina with hexanes-dichloromethane 50:1 to give a 
pale yellow solid (42 mg, 0.11 mmol, 31%). 
Mp 138-140 °C. Rf: 0.72 (hexanes-ethyl acetate, 7:1);  
IR (solid): 2958; 2921; 1638; 1602; 1509; 1455; 1273; 
1219; 1137; 1059; 1021; 818 cm
-1
.  
1
H NMR (250 MHz, CDCl3): δ = 1.04 ppm (s, 9H, 
CH3); 2.26 ppm (s, 3H, CH3); 2.27 ppm (s, 3H, CH3); 
6.57 ppm (d, J = 7.9 Hz; 1H, Ar-H); 6.71 ppm (dt, J = 
8.6 Hz and 4.4 Hz, 1H, Ar-H); 7.00 ppm (s, 1H, Ar-
H); 7.03 – 7.15 ppm (m, 10H, Ar-H). 
13
C NMR (62.5 Hz, CDCl3): δ = 21.43; 21.45; 27.5; 
37.28; 120.7; 122.0; 125.5; 125.9; 127.0; 128.4; 
129.6; 129.8; 129.9; 130.8; 136.4; 137.2; 137.3; 
137.8; 141.1; 141.3; 167.3. 
MS (EI, 70 eV): m/z (%): 381 (100%); 324 (50%); 
310 (32%); 296 (15%); 281 (18%); 179 (33%); 57 
(35%). 
4-(bis(3-methylphenyl)methylene)-2-tert-butyl-4H-
benzo[d][1,3]oxazine
10 
(5j)  
Prepared according to the general procedure from N-
(2-((3-methylphenyl)ethynyl)phenyl)pivalamide 
(102.0 mg, 0.35 mmol) with (3-
methylphenyl)(mesityl)iodonium 
trifluoromethanesulfonate (204.2 mg 0.42 mmol) 
Reaction time: 12 h. The crude product was purified 
by column chromatography on Brockmann II type 
neutral alumina with hexanes-dichloromethane 100:1 
to give a yellow solid (81 mg, 0.21 mmol, 61%). 
Mp 103-105 °C. Rf: 0.79 (hexanes-ethyl acetate, 7:1);  
IR (solid): 3033, 2958, 2924, 1642, 1598, 1456, 1218, 
1137, 1063 cm
-1
. 
1
H NMR (250 MHz, CDCl3): δ = 1.03 ppm (s, 9H, 
CH3); 2.18 ppm (s,3H, CH3); 2.23 ppm (s, 3H, CH3); 
6.53 ppm (d, J = 8.1 Hz, 1H, Ar-H); 6.69 ppm (ddd, J 
= 8.4 Hz and 5.3 Hz and 3.4 Hz, 1H, Ar-H); 6.92 – 
7.01 ppm (m, 5H, Ar-H); 7.05 – 7.13 ppm (m, 5H, Ar-
H). 
13
C NMR (62.5 Hz, CDCl3): δ = 21.5; 21.6; 27.5; 
37.3; 120.9; 121.8; 125.6; 126.0; 127.00; 127.03; 
127.5; 127.6; 127.8; 128.3; 128.9; 129.8; 130.7; 
131.4; 137.0; 138.7; 140.0; 140.5; 141.3; 141.4; 
167.2. 
MS (EI, 70 eV): m/z (%): 381 (100%); 324 (48%); 
310 (37%); 281 (15%); 178 (24%); 57 (28%). 
4-(bis(4-chlorophenyl)methylene)-2-tert-butyl-4H-
benzo[d][1,3]oxazine
10 
(5k)  
Prepared according to the general procedure from N-
(2-((4-chlorophenyl)ethynyl)phenyl)pivalamide 
(109.1 mg, 0.35 mmol) with (4-
chlorophenyl)(mesityl)iodonium trifluoromethane 
sulfonate (212.8 mg 0.42 mmol) Reaction time: 24 h. 
The crude product was purified by column 
chromatography on Brockmann II type neutral 
alumina with hexanes-dichloromethane 100:1 to give 
a pale yellow solid (87 mg, 0.21 mmol, 59%). 
Mp 120-122 °C. Rf: = 0.79 (hexanes-ethyl acetate, 
7:1);  
IR (solid): 2963; 1636; 1608; 1585; 1489; 1455; 1217; 
1140; 1088; 1012; 827 cm
-1
. 
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1
H NMR (250 MHz, CDCl3): δ = 1.13 ppm (s, 9H, 
CH3); 6.67 ppm (d, J = 7.9 Hz, 1H, Ar-H); 6.87 ppm 
(t, J = 7.0 Hz, 1H, Ar-H); 7.16 ppm (d, J = 8.5 Hz, 
2H, Ar-H); 7.22 ppm (d, J = 6.4 Hz, 4H, Ar-H); 7.35 – 
7.26 ppm (m, 4H, Ar-H). 
13
C NMR (62.5 Hz, CDCl3): δ = 27.6; 37.3; 118.1; 
121.0; 126.0; 126.3; 126.9; 128.1; 129.5; 130.4; 
131.4; 132.4; 132.7; 133.7; 138.2; 138.9; 141.4; 
142.6; 166.8. 
MS (EI, 70 eV): m/z (%): 421 (91%); 364 (42%); 329 
(52%); 301 (35%); 267 (45%); 239 (45%); 199 (90%); 
190 (22%); 163 (57%); 57 (100%). 
4-(diphenylmethylene)-2-phenyl-4H-
benzo[d][1,3]oxazine
 10
(5l) 
N-(2-(phenylethynyl)phenyl)benzamide (104.1 mg, 
0.35 mmol, 1.0 equiv.), aryl(mesityl)iodonium 
trifluoromethane sulfonate (198.3 mg, 0.42 mmol, 1.2 
equiv.) and Cu/Fe (22.2 mg, 0.0175 mmol, 5 mol%) 
were placed in a 4 ml vial, which was sealed with 
rubber septa, evacuated then charged with argon. 1,2-
dichloroethane (3 ml) was added, and the reaction 
mixture was stirred at 50°C for 17 hours. The catalyst 
was separated from the reaction mixture with a 
magnet. The reaction mixture was diluted with 
CH2Cl2 (15 ml), washed twice with saturated sodium 
bicarbonate solution (15 ml), the aqueous phase was 
extracted with CH2Cl2 (15 ml), and the combined 
organic phases were dried over magnesium sulfate and 
the solvent was evaporated in vacuo. The crude 
product was purified by column chromatography on 
silica gel with hexane-ethyl acetate 50:1 to give a 
bright yellow solid (91 mg, 0.24 mmol, 70%). 
Mp 187 – 189 °C. Rf = 0.64 (hexanes-ethyl acetate, 
7:1);  
IR (solid): 3055; 1738; 1633; 1612; 1591; 1574; 1449; 
1243; 1069; 1024 cm
-1
. 
1
H NMR (250 MHz, CDCl3): δ = 6.58 ppm (d, J= 7.8 
Hz, 1H, Ar-H); 6.72 ppm (t, J= 7.6 Hz, 1H, Ar-H); 
7.11 ppm (t, J= 7.5 Hz, 1H, Ar-H); 7.35 – 7.19 ppm 
(m, 14H, Ar-H); 7.79 ppm (d, J= 7.4 Hz, 2H, Ar-H).  
13
C NMR (62.5 MHz, CDCl3): δ = 121.5; 122.0; 
126.0; 126.4; 127.1; 127.2; 127.7; 128.0; 128.1; 
128.4; 129.2; 130.1; 130.9; 131.2; 131.7; 140.1; 
140.6; 141.5; 141.6; 156.2. 
MS (EI, 70 eV): m/z (%): 373 (97%); 356 (10%); 344 
(66%); 267 (20%); 239 (42%); 179 (30%); 165 
(100%); 77 (20%). 
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